Dermatology

Breast Cancer, Non-metastatic

Questions discussed in this category

Do you offer adjuvant radiation therapy for a breast cancer patient with dermatomyositis?

If so, what dose-fractionation do you utilize? What other factors do you take into consideration?

2 Answers available

Can you continue checkpoint inhibitor therapy in the setting of severe cutaneous irAE while concurrently treating the cutaneous reaction?

2 Answers available

Papers discussed in this category

J Immunother Cancer,

Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy.

Related Topics in Dermatology